1. Home
  2. Vol 5, No 2 (2023)
  3. Khaerunnisa

Penambatan Molekul Senyawa Swietemacrophyllanin dari Kulit Batang Mahoni (Swietenia macrophylla King,) sebagai Inhibitor Enzim Alfa Glukosidase

Arini Khaerunnisa, Ratna Djamil, Lilik Sulastri, Tarso Rudiana, Partomuan Simanjuntak

Abstract


Mahogany (Swietenia macrophylla King.) is one of the plants used as an antidiabetic agent. 96% ethanol extract of S. macrophylla stem bark can inhibit the α-glucosidase enzyme. Methanol and aqueous extracts of S. macrophylla stem bark can reduce rat blood glucose levels induced by streptozotocin. Molecular docking is one of the most widely used structural-based drug design strategies due to its wide application in the analysis of binding energy and molecular interactions between drug compounds and receptors. This study aims to identify the compounds in the stem bark of S. macrophylla and analyze the molecular anchoring of the compounds produced by the aid. The research was carried out by means of the water fraction of the stem bark of S. macrophylla and was purified by column chromatography. Fraction 2 was identified by LCMS-MS. Molecular docking using AutoDock 4.2.6. The results of Fraction 2 showed the presence of catechins, evodionol, swietemacrophyllanin, swietenitin K and β-sitosterol. The results of an in-silico study showed that swietemacrophyllanin provided a better affinity than acarbose with a binding energy value of -8.57 kcal/mol and an inhibition constant of 0.52 µM. Forms hydrogen bonds with catalytic residues (Glu277 and Asp352) from the active site of the α-glucosidase enzyme. Swietemacrophyllanin has potential as an antidiabetic agent

Keywords


In silico, Inhibitor enzim α-glukosidase, Swietemacrophyllanin, Swietenia macrophylla King.,

References


Alberti KGMM (2010). Textbook of Diabetes. Fourth Edi. (Holt RI., Cockram CS, Elyvbjreg A, Goldstein BJ, eds.). Wiley-Blackwell.

Bakar NFA, Bakeri NA, Salleh LM, et al. (2020) Extraction of Swietenia macrophylla seed oil using supercritical carbon dioxide technique and its antioxidant, antidiabetic and toxicity properties. Chem Eng Trans. 78:523-528.

Chaudhary KK, Mishra N. A (2016). Review on Molecular Docking: Novel Tool for Drug Discovery. JSM Chem. 4(3):1029.

Dipiro J, Talbert RL, Yee GC, et al. (2015). Pharmacoterapy A Phatophysiologic Approach.

Falah S, Safithri M, Katayama T, et al. (2010). Hypoglycemic Effect of Mahogany (Swietenia macrophylla King.) Bark Extracts in Alloxan-induced Diabetic Rats. Wood Res J.1(2):89-94.

Falah S, Suzuki T, Katayama T. (2012). Chemical constituents from S.macrophylla bark and their antioxidant activity. Pakistan J Biol Sci. 11(16):2007-2012

Fasciotti M, Alberici RM, Cabrai EC, et al. (2013). Wood Chemotaxonomy via ESI-MS profiles of phytochemical markers: The challenging case of African versus Brazilian Mahogany woods. AIChE Annual Meet Conf Proc. Published online.

Garcia UG, Benito-Vicente A, Jebari S, et al. (2020). Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 21(17):1-34.

Hashim MA, Yam MF, Hor SY, et al. (2013). Anti-hyperglycaemic activity of Swietenia macrophylla king (Meliaceae) seed extracts in normoglycaemic rats undergoing glucose tolerance tests. Chinese Med (United Kingdom). 8(1):1-8.

Kemenkes RI (2020). Tetap produktif, cegah dan atasi diabetes mellitus. Pusat data dan Informasi kementrian Kesehatan RI. Published online.

Khaerunnisa A. Djamil R, Sulastri S dkk. (2022). Aktivitas Fraksi Air Kulit Batang Mahoni (Swietenia macrophylla King.) dan Studi In silico Senyawa Kimia Penghambat Enzim α-Glukosidase). Jurnal Fitofarmaka Indonesia. 9(1): 6-14.

Lin BD, Zhang CR, Yang SP, et al. (2011). Phragmalin-type limonoid orthoesters from the twigs of Swietenia macrophylla. Chem Pharm Bull. 59(4):458-465.

Mousa OM, Issa MY, El-Askary HI, et al., (2014).Lipoidal composition and bioactivity of leaves and barks of Swietenia mahogani and Swietenia macrophylla grown in Egypt. 3(4):187-212.

Perera WH. Shivanagoudra SR. Perez JL et al. (2021). Anti-inflammatory, antidiabetic properties and in silico modeling of cucurbitane-type triterpene glycosides from fruits of an Indian cultivar of Momordica charantia L. Molecules. 26(1038): 2-18.

Rachmatiah T, Permatasari D, Dewi T, et al., (2015). Potensi antidiabetes pada daun, kulit batang dan biji mahoni (Swietenia macrophylla King). Sainstech. 25(2):88-91.

Ramadhan R, Phuwapraisirisan P, Kusuma IW, Amirta R. (2020). Ethnopharmacological evaluation of selected east kalimantan flora for diabetes therapy: The isolation of lupane triterpenoids as α-glucosidase inhibitors from ceriops tagal (perr) c.b.robb. Rasayan J Chem. 13(3):1727-1734.

Rammohan A, Bhaskar BV, Venkateswarlu N, et al. (2020). Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents. Bioorg Chem. 95(August 2019):103527.

Sari BL, Mun’Im A, Yanuar A, et al.. (2016). Screening of α-glucosidase inhibitors from Terminalia catappa L. Fruits using molecular docking method and in vitro test. Int J Pharm Pharm Sci. 8(12):184-189.

Tian L, Teng X, Zhong C, et al. (2015). Chemical Constituents from the Barks of Swietenia macrophylla. Gen Chem. 1(1):22-25.

World Health Organization (2016). Global Report on Diabetes. Publication on the World Health Organization.


Full Text: PDF

DOI: 10.15408/pbsj.v5i2.32926

Refbacks

  • There are currently no refbacks.